Cargando…

Outcome Measures in Multiple Sclerosis

Detalles Bibliográficos
Autores principales:	Bermel, Robert, Waldman, Amy, Mowry, Ellen M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4026968/ https://www.ncbi.nlm.nih.gov/pubmed/24883206 http://dx.doi.org/10.1155/2014/439375

Ejemplares similares

Outcome Measures in Relapsing-Remitting Multiple Sclerosis: Capturing Disability and Disease Progression in Clinical Trials
por: Lavery, Amy M., et al.
Publicado: (2014)

Early Aggressive Treatment Approaches for Multiple Sclerosis
por: Simpson, Alexandra, et al.
Publicado: (2021)

Immunoglobulin G immune response to SARS-CoV-2 vaccination in people living with multiple sclerosis within Multiple Sclerosis Partners Advancing Technology and Health Solutions
por: Cohen, Jeffrey A, et al.
Publicado: (2022)

The MSOAC approach to developing performance outcomes to measure and monitor multiple sclerosis disability
por: LaRocca, Nicholas G, et al.
Publicado: (2017)

The relationship between cognition, education, and employment in multiple sclerosis patients
por: Conway, Devon S, et al.
Publicado: (2022)

Multiple Sclerosis Performance Test: Technical Development and Usability
por: Rhodes, Jane K., et al.
Publicado: (2019)

Evaluation of multiple sclerosis disability outcome measures using pooled clinical trial data
por: Goldman, Myla D., et al.
Publicado: (2019)

Obesity's role in MS: An intervention target with possible interactions
por: Fitzgerald, Kathryn C., et al.
Publicado: (2020)

The Calm Between Storms: Serum Biomarkers in Assessing Interattack Astrocytopathy in Neuromyelitis Optica Spectrum Disorder
por: Goldschmidt, Carolyn, et al.
Publicado: (2021)

Obtaining Patient Priorities in a Multiple Sclerosis Comprehensive Care Center: Beyond Patient-Reported Outcomes
por: Miller, Deborah M, et al.
Publicado: (2019)

Multiple sclerosis management during the COVID-19 pandemic
por: Moss, Brandon P, et al.
Publicado: (2020)

Multiple Sclerosis
por: Ramagopalan, Sreeram, et al.
Publicado: (2011)

Providing Person-Centered Care via Telemedicine in the Era of COVID-19 in Multiple Sclerosis
por: Abbatemarco, Justin R, et al.
Publicado: (2021)

Retinal measurements predict 10‐year disability in multiple sclerosis
por: Rothman, Alissa, et al.
Publicado: (2019)

Multiples sclerosis in India
por: Khadilkar, Satish V.
Publicado: (2015)

Multiple Sclerosis in India
por: Goyal, Vinay
Publicado: (2018)

Leveraging real-world data to investigate multiple sclerosis disease behavior, prognosis, and treatment
por: Cohen, Jeffrey A, et al.
Publicado: (2019)

Association of Vitamin D Polygenic Risk Scores and Disease Outcome in People With Multiple Sclerosis
por: Vasileiou, Eleni S., et al.
Publicado: (2022)

Prospects of siponimod in secondary progressive multiple sclerosis
por: McGinley, Marisa, et al.
Publicado: (2018)

Clinical features and outcomes of COVID-19 despite SARS-CoV-2 vaccination in people with multiple sclerosis
por: Rose, Deja R, et al.
Publicado: (2021)

Multiple Sclerosis Susceptibility Genes: Associations with Relapse Severity and Recovery
por: Mowry, Ellen M., et al.
Publicado: (2013)

Outcome Measures in Clinical Trials for Multiple Sclerosis
por: van Munster, Caspar E. P., et al.
Publicado: (2017)

IL-11 in multiple sclerosis
por: Zhang, Xin, et al.
Publicado: (2015)

Advances in Multiple Sclerosis 2017
por: Göbel, Kerstin, et al.
Publicado: (2018)

Molecular Research in Multiple Sclerosis
por: Fucito, Maurine, et al.
Publicado: (2022)

Association of Multiple Sclerosis Susceptibility Variants and Early Attack Location in the CNS
por: Mowry, Ellen M., et al.
Publicado: (2013)

Multiple Sclerosis: From Molecules to Treatment
por: Broadley, Simon A
Publicado: (2013)

Improving communication with multiple sclerosis patients
por: Alroughani, Raed A.
Publicado: (2015)

Sequencing the immunopathologic heterogeneity in multiple sclerosis
por: Antel, Jack P, et al.
Publicado: (2015)

Multiple Sclerosis, Viruses, and New Vaccines
por: Maple, Peter A. C.
Publicado: (2021)

Digital Innovation in Multiple Sclerosis Management
por: Ziemssen, Tjalf, et al.
Publicado: (2021)

Vaccine hesitancy in people with multiple sclerosis
por: Lechner-Scott, Jeannette S, et al.
Publicado: (2022)

Personalized Diagnosis and Therapy for Multiple Sclerosis
por: Ramo-Tello, Cristina
Publicado: (2022)

How patients with multiple sclerosis acquire disability
por: Lublin, Fred D, et al.
Publicado: (2022)

Improving the efficiency of clinical trials in multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2023)

Using real-world accelerometry-derived diurnal patterns of physical activity to evaluate disability in multiple sclerosis
por: Keller, Jennifer L., et al.
Publicado: (2022)

Remyelination therapy goes to trial for multiple sclerosis
por: Brugarolas, Pedro, et al.
Publicado: (2014)

Molecule of the month: miRNA and Multiple Sclerosis
por: Shapshak, Paul
Publicado: (2013)

Neuropsychological Features of Multiple Sclerosis: Impact and Rehabilitation
por: Messinis, Lambros, et al.
Publicado: (2018)

The Long Road of Immunotherapeutics against Multiple Sclerosis †
por: Apostolopoulos, Vasso, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4mb1cped2fgg0hbtp56d9b0u38